CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-04 | ROBINS CHAD M CEO and Chairman | Grant or award | +247,117 | 1,920,578 | ||
| 2022-03-04 | ADAMS R MARK Chief Operating Officer | Grant or award | +74,135 | 124,968 | ||
| 2022-03-04 | ADAMS R MARK Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +185,338 | 185,338 | ||
| 2022-01-26 | Pellini Michael J Director | Grant or award | +6,689 | 8,193 | ||
| 2022-01-26 | Pellini Michael J Director | Grant or award · Stock Option (Right to Buy) | +16,722 | 16,722 | ||
| 2022-01-26 | Conroy Kevin T Director | Grant or award | +6,689 | 8,193 | ||
| 2022-01-26 | Conroy Kevin T Director | Grant or award · Stock Option (Right to Buy) | +16,722 | 16,722 | ||
| 2022-01-26 | GRIFFIN MICHELLE RENEE Director | Grant or award | +6,689 | 8,193 | ||
| 2022-01-26 | GRIFFIN MICHELLE RENEE Director | Grant or award · Stock Option (Right to Buy) | +16,722 | 16,722 | ||
| 2022-01-26 | HERSHBERG ROBERT Director | Grant or award | +6,689 | 8,193 | ||
| 2022-01-26 | HERSHBERG ROBERT Director | Grant or award · Stock Option (Right to Buy) | +16,722 | 16,722 | ||
| 2022-01-26 | NEUPERT PETER M Director | Grant or award | +6,689 | 8,193 | ||
| 2022-01-26 | NEUPERT PETER M Director | Grant or award · Stock Option (Right to Buy) | +16,722 | 16,722 | ||
| 2022-01-26 | OWEN KATEY EINTERZ Director | Grant or award | +6,689 | 11,132 | ||
| 2022-01-26 | OWEN KATEY EINTERZ Director | Grant or award · Stock Option (Right to Buy) | +16,722 | 16,722 | ||
| 2022-01-26 | Trigg Leslie Director | Grant or award | +6,689 | 11,132 | ||
| 2022-01-26 | Trigg Leslie Director | Grant or award · Stock Option (Right to Buy) | +16,722 | 16,722 | ||
| 2022-01-07 | ADAMS R MARK Chief Operating Officer | Sale | −1,021 | $23.32 | $24K | 50,833 |
| 2021-12-22 | Taylor Stacy L SVP and General Counsel | Option exercise | +10,130 | $6.55 | $66K | 25,166 |
| 2021-12-22 | Taylor Stacy L SVP and General Counsel | Option exercise | +5,208 | $7.80 | $41K | 30,374 |
Page 37 of 120 · 2,386 trades